Bristol-Myers Hepatitis Drug Effective - FDA Staff

WASHINGTON (Reuters) - Bristol-Myers Squibb Co.'s. experimental drug for chronic hepatitis B infection is effective in treating the liver disease, but also raises questions about cancer risks, U.S. regulatory staff said in documents released on Thursday.

Continue to Bristol-Myers Hepatitis Drug Effective - FDA Staff on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz